LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Colon Cancer Screen 32 Tissue Microarray - LS-SCOCA32

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SCOCA32
Product Name: Colon Cancer Screen 32
Description: Colon cancer with stage/grade
Format: FFPE
Category: Human Tumor
QA/QC: H&E reviewed
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: Yes
Core Diameter: 1.5 mm
Core Thickness: 5 µm
Cases: 24
Cores: 72
Slides Per Set: 1

LS-SCOCA32 Tissue Microarray Map

Slide Number 1
LABEL
 123456789
AColColColColColColColColCol
BColColColColColColColColCol
CColColColColColColColColCol
DColColColColColColColColCol
EColColColColColColColColCol
FColColColColColColColColCol
GColColColColColColColColCol
HColColColColColColColColCol
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Colon (Col);

LS-SCOCA32 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis TypeTNM Tumor ClassificationTumor Grade
1A1HumanM77 yColon (Col)Adenocarcinoma, PapillaryMalignantT3N0M01
1A2HumanM77 yColon (Col)Adenocarcinoma, PapillaryMalignantT3N0M01
1A3HumanM77 yColon (Col)Adenocarcinoma, TubulopapillaryMalignantT3N0M01
1A4HumanM69 yColon (Col)AdenocarcinomaMalignantT3N1M01
1A5HumanM69 yColon (Col)AdenocarcinomaMalignantT3N1M01
1A6HumanM69 yColon (Col)AdenocarcinomaMalignantT3N1M01
1A7HumanF60 yColon (Col)AdenocarcinomaMalignantT3N1M01
1A8HumanF60 yColon (Col)AdenocarcinomaMalignantT3N1M01-2
1A9HumanF60 yColon (Col)AdenocarcinomaMalignantT3N1M01
1B1HumanM52 yColon (Col)AdenocarcinomaMalignantT2N0M02
1B2HumanM52 yColon (Col)AdenocarcinomaMalignantT2N0M02
1B3HumanM52 yColon (Col)AdenocarcinomaMalignantT2N0M02
1B4HumanF68 yColon (Col)AdenocarcinomaMalignantT3N1M01
1B5HumanF68 yColon (Col)AdenocarcinomaMalignantT3N1M01
1B6HumanF68 yColon (Col)AdenocarcinomaMalignantT3N1M01
1B7HumanM73 yColon (Col)AdenocarcinomaMalignantT3 N01
1B8HumanM73 yColon (Col)AdenocarcinomaMalignantT3 N01
1B9HumanM73 yColon (Col)AdenocarcinomaMalignantT3 N01
1C1HumanM75 yColon (Col)AdenocarcinomaMalignantT2N1M02
1C2HumanM75 yColon (Col)AdenocarcinomaMalignantT2N1M02
1C3HumanM75 yColon (Col)AdenocarcinomaMalignantT2N1M02
1C4HumanM59 yColon (Col)Adenocarcinoma, MucinousMalignantT3N1M02
1C5HumanM59 yColon (Col)Adenocarcinoma, MucinousMalignantT3N1M02
1C6HumanM59 yColon (Col)Adenocarcinoma, MucinousMalignantT3N1M02
1C7HumanF82 yColon (Col)AdenocarcinomaMalignantT3N0M02
1C8HumanF82 yColon (Col)AdenocarcinomaMalignantT3N0M02
1C9HumanF82 yColon (Col)AdenocarcinomaMalignantT3N0M02
1D1HumanF45 yColon (Col)AdenocarcinomaMalignantT1N0M02
1D2HumanF45 yColon (Col)AdenocarcinomaMalignantT1N0M02
1D3HumanF45 yColon (Col)AdenocarcinomaMalignantT1N0M02
1D4HumanF72 yColon (Col)AdenocarcinomaMalignantT3N0M02
1D5HumanF72 yColon (Col)AdenocarcinomaMalignantT3N0M02
1D6HumanF72 yColon (Col)AdenocarcinomaMalignantT3N0M02
1D7HumanF65 yColon (Col)AdenocarcinomaMalignantT3N1M03
1D8HumanF65 yColon (Col)AdenocarcinomaMalignantT3N1M03
1D9HumanF65 yColon (Col)AdenocarcinomaMalignantT3N1M03
1E1HumanF30 yColon (Col)AdenocarcinomaMalignantT3N1M02-3
1E2HumanF30 yColon (Col)AdenocarcinomaMalignantT3N1M02-3
1E3HumanF30 yColon (Col)AdenocarcinomaMalignantT3N1M02-3
1E4HumanF66 yColon (Col)AdenocarcinomaMalignantT3N1M03
1E5HumanF66 yColon (Col)AdenocarcinomaMalignantT3N1M03
1E6HumanF66 yColon (Col)AdenocarcinomaMalignantT3N1M03
1E7HumanM60 yColon (Col)AdenocarcinomaMalignantT3N1M02
1E8HumanM60 yColon (Col)AdenocarcinomaMalignantT3N1M02
1E9HumanM60 yColon (Col)AdenocarcinomaMalignantT3N1M02-3
1F1HumanM76 yColon (Col)AdenocarcinomaMalignantT3N0M02
1F2HumanM76 yColon (Col)AdenocarcinomaMalignantT3N0M0
1F3HumanM76 yColon (Col)AdenocarcinomaMalignantT3N0M02
1F4HumanF30 yColon (Col)AdenocarcinomaMalignantT3N1M03
1F5HumanF30 yColon (Col)AdenocarcinomaMalignantT3N1M03
1F6HumanF30 yColon (Col)AdenocarcinomaMalignantT3N1M03
1F7HumanM71 yColon (Col)AdenocarcinomaMalignantT2N0M03
1F8HumanM71 yColon (Col)Adenocarcinoma with necrosisMalignantT2N0M03
1F9HumanM71 yColon (Col)AdenocarcinomaMalignantT2N0M03
1G1HumanM47 yColon (Col)Adjacent normalBenign non-neoplastic  
1G2HumanM47 yColon (Col)Adjacent normalBenign non-neoplastic  
1G3HumanM47 yColon (Col)Adjacent normalBenign non-neoplastic  
1G4HumanM65 yColon (Col)Adjacent normalBenign non-neoplastic  
1G5HumanM65 yColon (Col)Adjacent normalBenign non-neoplastic  
1G6HumanM65 yColon (Col)Adjacent normalBenign non-neoplastic  
1G7HumanM33 yColon (Col)Adjacent normalBenign non-neoplastic  
1G8HumanM33 yColon (Col)Adjacent normalBenign non-neoplastic  
1G9HumanM33 yColon (Col)Adjacent normalBenign non-neoplastic  
1H1HumanM30 yColon (Col)NormalBenign non-neoplastic  
1H2HumanM30 yColon (Col)NormalBenign non-neoplastic  
1H3HumanM30 yColon (Col)NormalBenign non-neoplastic  
1H4HumanM40 yColon (Col)NormalBenign non-neoplastic  
1H5HumanM40 yColon (Col)NormalBenign non-neoplastic  
1H6HumanM40 yColon (Col)NormalBenign non-neoplastic  
1H7HumanM30 yColon (Col)NormalBenign non-neoplastic  
1H8HumanM30 yColon (Col)NormalBenign non-neoplastic  
1H9HumanM30 yColon (Col)NormalBenign non-neoplastic  
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved